Physician profile
Crystal Drayer
NPI 1114377116
$3,543.13
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2021: $13.33 · 2022: $22.84 · 2023: $1,757 · 2024: $1,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,744 · Food and Beverage: $1,331 · Gift: $24.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,743.57 |
| Food and Beverage | $1,330.58 |
| Gift | $24.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,536.34 | 2022-2024 | Da Vinci Surgical System |
| Tela Bio, INC. | $435.28 | 2019-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Mallinckrodt Enterprises LLC | $121.08 | 2019 | |
| Pfizer INC. | $113.68 | 2019 | |
| Ardelyx, INC. | $83.13 | 2023 | Ibsrela |
| Edwards Lifesciences Corporation | $52.74 | 2019 | |
| Coloplast Corp | $50.74 | 2023 | Sensura Mio |
| Z-Medica, LLC | $47.67 | 2019 | |
| Allergan, INC. | $40.54 | 2019 | |
| Davol INC. | $29.05 | 2023 | Phasix Mesh |
| Ethicon US, LLC | $19.55 | 2023 | Echelon Circular |
| Kci USA, INC. | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Drayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.